Adocia Mutual Funds | StatInvestor

Health Care & Life Sciences » Biotechnology | Adocia

Adocia | Mutual Funds

Mutual Funds that own Adocia

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Talence Sélection PME

45,000

0.65%

0.92%

07/31/2018

Boscary Uzès Sélection

23,000

0.33%

1.24%

08/31/2018

13,000

0.19%

13,000

1.54%

06/30/2017

AcomeA Europa

8,517

0.12%

0.14%

10/31/2017

Julius Baer Multirange - Allround QUADInvest Growth

7,000

0.1%

0.15%

02/28/2018

CPR Actions France

6,646

0.1%

5,924

0.06%

12/30/2016

Monega Innovation

6,150

0.09%

0.2%

07/31/2018

Simbad Actions France

5,516

0.08%

0.01%

01/31/2018

Deka - EuropaPotential CF

5,500

0.08%

5,500

0.09%

06/29/2018

Fédéral Optimal

5,000

0.07%

0.16%

10/31/2016

About Adocia

View Profile

Address	115 avenue Lacassagne Lyon Rhone-Alpes 69003 France
Employees	-
Website	http://www.adocia.com
Updated	07/08/2019
Adocia SA is a clinical-stage biotechnology company, which engages in the development of medicines from already-approved therapeutic proteins and peptides. Its product pipelines include: BioChaperone Lispro; BioChaperone Combo; HinsBet; BioChaperone Human Glucagon; BioChaperone Glargine GLP-1; and BioChaperone Prandaial Combinations for T1D. The company was founded by Gérard, Olivier, and Rémi Soula on December 16, 2005 and is headquartered in Lyon, France.